| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |